Loading...
•
Dec 31, 2023
Cross Country Healthcare Q4 2023 Earnings Report
Announced fourth quarter and full year 2023 financial results.
Key Takeaways
Cross Country Healthcare's Q4 2023 revenue was $414.0 million, a decrease of 34% year-over-year. Net income attributable to common stockholders was $9.0 million, and diluted EPS was $0.26. The company proactively managed its cost structure, repaid $73.9 million on the term loan, and invested over $20 million in core technologies.
Fourth quarter Revenue exceeded the high end of guidance range
Physician Staffing and Education experienced annual double-digit year-over-year revenue growth
Proactively managed cost structure and drove a full year adjusted EBITDA margin of over 7%
Repaid $73.9 million on the term loan and paid down the ABL, ending the year debt-free
Revenue by Segment
Forward Guidance
The company expects Q1 2024 revenue to be between $370 million and $380 million, with adjusted EBITDA between $13.0 million and $18.0 million, and adjusted EPS between $0.15 and $0.25.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...